Virtu Financial’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-28,917
Closed -$616K 2066
2024
Q1
$616K Buy
+28,917
New +$346K 0.05% 352
2023
Q2
Sell
-13,084
Closed -$49K 2228
2023
Q1
$49K Buy
+13,084
New +$51.5K 0.01% 1102

Virtu Financial's FUSN Position: Q2 2024 in Review

Virtu Financial sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 28,917 shares — an estimated $616K sold.

Virtu Financial first reported a position in FUSN in Q1 2023 and held it in 2 quarters. The position peaked at $616K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Virtu Financial reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 28,917 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $616K.
  • Virtu Financial first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2023 and held it in 2 quarters.
  • Virtu Financial's Fusion Pharmaceuticals Inc. Common Shares position peaked at $616K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.